Klee Justin B. — SEC Form 4 filings

SEC reporting owner CIK 1898314. 20 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2024-01-11 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Amylyx Pharmaceuticals, Inc. (AMLX)Co-Chief Executive Officer, Director2016 legs · 325,100 sh · $4,418,23717

Form 4 filings — Klee Justin B.

FiledFormIssuerReported transactionsSource
2026-09-144Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,025 @ $32.13 · Sale (S): 1,439 @ $33.16EDGAR
2026-08-204Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 60,039 @ $0EDGAR
2026-03-094Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 248,865 @ $0 · Grant/award (A): 373,295 (derivative) @ $0EDGAR
2026-03-044Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,282 @ $14.47EDGAR
2026-02-044Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 15,500 @ $14.69EDGAR
2026-01-204Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 197,153 @ $7.57 · Sale (S): 136,193 @ $13.58 · Option exercise (M): 2,847 @ $7.57 · Sale (S): 1,995 @ $13.89 · Option exercise (M): 197,153 (derivative) @ $0 · Option exercise (M): 2,847 (derivative) @ $0EDGAR
2026-01-084Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 7,715 @ $11.09EDGAR
2025-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,775 @ $14.37 · Sale (S): 200 @ $15.01EDGAR
2025-04-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 21,490 @ $3.46EDGAR
2025-03-104Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 180,118 @ $0 · Grant/award (A): 270,177 (derivative) @ $0EDGAR
2025-03-054Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 4,595 @ $3.15EDGAR
2025-02-064Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 36,310 @ $1.57 · Option exercise (M): 36,310 (derivative) @ $0EDGAR
2025-02-054Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 11,855 @ $3.47EDGAR
2025-01-084Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 7,471 @ $4.04EDGAR
2024-11-064Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 63,690 @ $1.57 · Option exercise (M): 63,690 (derivative) @ $0EDGAR
2024-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 18,589 @ $3.20EDGAR
2024-04-184Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 179,850 @ $0 · Grant/award (A): 380,000 (derivative) @ $0EDGAR
2024-03-074Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 4,135 @ $18.73EDGAR
2024-02-284Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 126,667 @ $0 · Grant/award (A): 190,000 (derivative) @ $0EDGAR
2024-01-114Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 5,841 @ $16.33EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1898314 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →